Interest in GBA1, as a causative factor for PD, was initially sparkled by the observation, in the 1990s, that among GD patients and GBA1 mutation carriers, a higher proportion developed parkinsonian symptoms (Neudorfer et al., 1996; Machaczka et al., 1999). This evidence concerns the gene GBA1 and Parkinson disease.